Becker's Healthcare December 6, 2022
Understanding and addressing patients’ health determinants, including their genomic data, is crucial to tailoring care, improving outcomes and reducing costs — and is a key pillar of personalized medicine.
During Becker’s 10th Annual CEO + CFO Roundtable, in a session sponsored by Illumina, an applied genomics technology company, Damon Hostin, lead for health systems market access at Illumina, reviewed strategies for advancing the use of personalized medicine and addressed questions from participants.
Three key insights were:
1. The interplay between genomics and other factors is a growing area of focus in healthcare. Human biology is one dimension of human health that contributes to about 20 percent of overall health; other factors related to lifestyle, environmental and social determinants and access...
Today's Sponsors
Today's Sponsor